28
Oct
2025
Grace GmbH
Exhibitor at CPHI Frankfurt 2025 stand 5.1B58, Contract Manufacturing and Services
About Us
Categories
-
DE
-
2022On CPHI since
-
1000 - 4999Employees
Company types
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 5.1B58, Contract Manufacturing and Services
Products Featured at CPHI Frankfurt 2025
-
Product SYLOID® mesoporous silicas and VYVID™ superparamagnetic silicas
SYLOID® FP mesoporous silica is the ideal choice for formulations due to its unique morphology to help improve the handling, adsorption, and dissolution of many pharmaceuticals. - Effective desiccant to increase the stability of moisture-sensitive APIs - Efficient conditioner for powder formulations use... -
Product Custom Fine Chemical Manufacturing
Our comprehensive portfolio of services, integrated manufacturing, and regulatory leadership differentiates us as a leading contract development and manufacturing partner. With a proven ability to deliver solutions to complex challenges, Grace’s FCMS supports the entire small molecule development cycle fro... -
Product Generic APIs
Grace's Fine Chemical Manufacturing Services (FCMS) has a long history of supplying high-quality generic and custom APIs to the pharmaceutical and nutraceutical markets. Grace's FCMS has manufactured some of the most notable APIs that are now part of our portfolio of generic products available to devel... -
Product Multifunctional Excipients for the Nutraceutical and Pharmaceutical Industry
Our SYLOID® FP silica excipients are a strategic drug development tools in today’s challenging pharmaceutical industry with its demands for improved formulations, bringing new drugs to market faster, and technological advances.
SYLOID® FP silica’s unique, innovative design combine... -
Product Custom Bonding and Chromatography Resins for Small and Large Molecule Purification
Grace offers high quality chromatography silica resins with a wide range of pore diameters, particle sizes, and chromatography phases. We provide custom bonding of silica (30Å-4500Å; 5µm to 200µm) for different reversed and normal phases, ion exchange, and other chemistries. We develop and manufacture ... -
Product Drug Delivery for Enhanced Bioavailability of BCS2 (Poorly Soluble) Compounds
Engineered to bring together advanced silica technologies with challenging active pharmaceutical ingredients (APIs) to effectively formulate a large class of poorly soluble but otherwise promising compounds, Grace’s SILSOL® silica-based drug delivery technology provides solutions for poorly soluble active ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance